来自MSN1 个月
Merck Gets Positive CHMP Opinion for Keytruda in Mesothelioma
Merck MRK announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has rendered a positive opinion, recommending the approval of its blockbuster ...
Business Wire1 个月
Celltrion Receives Positive CHMP Opinion for Three Biosimilars in the European Union
INCHEON, South Korea--(BUSINESS WIRE)--Celltrion today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted positive opinions ...
来自MSN1 个月
European committee takes a second look at Alzheimer's drug and now says it should be approved
Biogen said Thursday that the drug, known in the U.S. as Leqembi, received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use as a treatment ...
GlobalData on MSN12 天
Ultragenyx’s Evkeeza secures EU approval for young children with rare cholesterol disorder
The decision follows a positive recommendation received from the Committee for Medicinal Products for Human Use (CHMP) in November 2024.
Healio1 个月
European committee issues positive opinion for Eylea biosimilar
Please provide your email address to receive an email when new articles are posted on . The Committee for Medicinal Products for Human Use of the European Medicines Agency granted a positive ...
ZIM Lab and Neuraxpharm announces grant of marketing authorization for "Buprenorphine ...
Buprenorphine is indicated for the substitution treatment of opioid drug dependence. According to IQVIA, the European market for Buprenorphine-based opioid dependency treatments in 2023 surpassed USD ...